Cat. No.: X24-08-YM341
Gap junction protein inhibitor, Tonabersat, Purity ≥98%
Synonym: 175013-84-0; SB-220453; N-[(3S,4S)-6-Acetyl-3-hydroxy-2,2-dimethyl-3,4-dihydrochromen-4-yl]-3-chloro-4-fluorobenzamide
- MDL: MFCD00944458
- CAS Number: 175013-84-0
- Compound CID: 6918324
Product Size
5 mg; 10 mg; 25 mg; 50 mg
Properties
Description
Tonabersat is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting gap junction protein.
Molecular Formula
C20H19ClFNO4
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Applications
Tonabersat is a cytoskeletal signaling inhibitor that can be used for its ability to modulate gap junction communication and potentially reduce neuronal excitability.
Related Products
-
Gap junction protein inhibitor, Gap 26, Purity ≥98%
-
Gap junction protein inhibitor, Gap 27, Purity ≥98%
-
Gap junction protein inhibitor, GnRH associated peptide (GAP) (1-13), human, Purity ≥98%
-
Gap junction protein inhibitor, 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, Scrambled 10Panx, Purity ≥98%
-
Gap junction protein inhibitor, GAP-134, Purity ≥98%
